X4 Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $1,434 | $560 | $563 | $0 |
Gross Profit | 1,132 | 333 | 295 | -62 |
EBITDA | -36,986 | -34,000 | -33,703 | -49,811 |
EBIT | -37,259 | -34,267 | -33,897 | -49,873 |
Net Income | -39,821 | -36,696 | 90,833 | -51,766 |
Net Change In Cash | 1,434 | 560 | 563 | 0 |
Free Cash Flow | -33,036 | -34,124 | -30,411 | -33,656 |
Cash | 55,699 | 97,412 | 147,218 | 60,493 |
Basic Shares | 201,062 | 200,865 | 200,801 | 199,991 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $2,557 | $0 | $0 | $0 |
Gross Profit | 1,760 | -1,996 | -1,994 | -1,892 |
EBITDA | -27,576 | -107,103 | -87,569 | -85,107 |
EBIT | -28,372 | -107,522 | -89,563 | -86,999 |
Net Income | -37,450 | -101,167 | -93,867 | -88,696 |
Net Change In Cash | 2,557 | 0 | 0 | 0 |
Cost of Revenue | 40,025 | |||
Free Cash Flow | -131,227 | -96,572 | -77,205 | -71,520 |
Cash | 55,699 | 99,216 | 121,718 | 81,787 |
Basic Shares | 201,062 | 177,812 | 63,526 | 25,749 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.20 |
2024-09-30 | -$0.18 |
2024-06-30 | -$0.07 |
2024-03-31 | -$0.26 |
